Charlotte Pawlyn is a Cancer Research UK Clinician Scientist and Team Leader at The Institute of Cancer Research and an Honorary Consultant Hematologist at The Royal Marsden Hospital in London, UK. She received her degrees in Pharmacology and Medicine from St John’s College, Cambridge University, UK. She completed initial medical training in the East Anglian and North London deaneries and her Hematology specialty training at the Royal Marsden Hospital and The Institute of Cancer Research, London. In 2016 Charlotte completed a Wellcome Trust funded PhD Fellowship, undertaking laboratory research to identify novel epigenetic targets for myeloma therapy. Her current laboratory research focusses on identifying therapeutic targets to improve outcomes for patients with immunomodulatory drug resistant and high-risk myeloma. In addition to her laboratory studies Charlotte is actively involved in the Trial Management Groups of several clinical trials as part of the UK Myeloma Research Alliance including the large national frontline studies, Myeloma XI and Myeloma XIV. She has published numerous peer-reviewed research papers and is a member of the Research Advisory Group for Myeloma UK.
EM-94002 - Date of preparation: April 2022